By Joanna Tan · AI in APAC · 30 September 2026

Melbourne-based Heidi Health has closed one of the larger healthcare-AI raises of the year: $100 million in Series C equity led by Blackbird, alongside a $240 million growth investment from General Catalyst’s Customer Value Fund, taking the company to a $900 million valuation. Phoenix Court, Point72 Private Investments, Headline, Possible Ventures, Glitch Capital and Archangel also joined the round, bringing Heidi’s total funding to date to roughly $436.6 million.

Heidi’s product is an “AI Care Partner” that sits alongside clinicians during patient visits, handling clinical notes, documentation and administrative workflow so doctors can spend more time actually looking at patients. The scale is already real: the platform has supported more than 175 million patient visits and 67 million clinical hours, and annual recurring revenue has grown from $1 million to $50 million in two years.

The APAC angle is the part worth watching. Alongside the raise, Heidi confirmed plans for a regional hub in Singapore, backed by an $8 million investment over three years. For a company that started as a tool for Australian GPs, that’s a deliberate bet that Southeast Asia’s hospitals and clinics — often stretched thin on clinician time — are ready for the same kind of AI-assisted documentation that has driven Heidi’s growth at home.

“From the day I started Heidi, the ambition was always bigger than writing doctors’ notes,” said co-founder and CEO Dr Thomas Kelly. “That’s the shift we’re now making: from documenting care to helping clinicians act on it.”

Source: DealStreetAsia, 23 September 2026.

Joanna Tan covers AI investment, policy and the business of AI for AIAPAC.ai Insights.